[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337652-105":59,"doc-detail-337652-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cancer-associated-fibroblasts-rewire-the-estrogen-receptor-response-in-luminal-breast-cancer-enabling-estrogen-independence","Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence","","Advanced breast cancers pose major therapeutic challenges because they resist standard treatments. Cancer-associated fibroblasts (CAFs), as abundant tumor microenvironment components, are linked to multiple cancer hallmarks, yet their impact on therapy outcomes is poorly mapped. Here, spatial coincidence of CAF infiltration with malignant cells correlates with reduced estrogen receptor (ER)-α expression and activity in luminal tumors. CAFs promote estrogen-independent tumor growth by selectively regulating ER-α signaling, suppressing most estrogen-responsive genes while preserving resistance, basal-like differentiation, and invasion programs.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-associated-fibroblasts-rewire-the-estrogen-receptor-response-in-luminal-breast-cancer-enabling-estrogen-independence/337652/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-associated-fibroblasts-rewire-the-estrogen-receptor-response-in-luminal-breast-cancer-enabling-estrogen-independence/337652.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How do cancer-associated fibroblasts influence estrogen receptor (ER)-α in luminal breast cancer?","Question",{"text":113,"@type":114},"Spatial CAF infiltration is associated with reduced ER-α expression and activity. CAFs also selectively modulate ER-α signaling to drive estrogen-independent tumor growth.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which gene programs are affected by CAF-mediated regulation of ER-α?",{"text":118,"@type":114},"Most prototypical estrogen-responsive genes are suppressed. At the same time, CAFs maintain gene expression linked to therapeutic resistance, basal-like differentiation, and invasion.",{"name":120,"@type":111,"acceptedAnswer":121},"What signaling pathways were identified as actionable targets to counter CAF effects on ER-α activity?",{"text":122,"@type":114},"A functional drug screen implicated effector pathways. Transforming Growth Factor-β and Janus kinase signaling cascades were validated as actionable targets.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337652,1790146496,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Oncogene [www.nature.com/onc](www.nature.com/onc)  \nARTICLE OPEN   \nCancer-associated ﬁbroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence  \nSteven E. Reid1, Jessica Pantaleo 1, Paulina Bolivar1, Matteo Bocci 1, Jonas Sjölund 1, Mikkel Morsing 1, Eugenia Cordero1, Sara Larsson 1, Maria Malmberg 1, Brinton Seashore-Ludlow2,3 and Kristian Pietras 1 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Advanced breast cancers represent a major therapeutic challenge due to their refractoriness to treatment. Cancer-associated ﬁbroblasts (CAFs) are the most abundant constituents of the tumor microenvironment and have been linked to most hallmarks of cancer. However, the inﬂuence of CAFs on therapeutic outcome remains largely unchartered. Here, we reveal that spatial coincidence of abundant CAF inﬁltration with malignant cells was associated with reduced estrogen receptor (ER)-α expression and activity in luminal breast tumors. Notably, CAFs mediated estrogen-independent tumor growth by selectively regulating ER-α signaling. Whereas most prototypical estrogen-responsive genes were suppressed, CAFs maintained gene expression related to therapeutic resistance, basal-like differentiation, and invasion. A functional drug screen in co-cultures identiﬁed effector pathways involved in the CAF-induced regulation of ER-α signaling. Among these, the Transforming Growth Factor-β and the Janus kinase signaling cascades were validated as actionable targets to counteract the CAF-induced modulation of ER-α activity. Finally, genes that were downregulated in cancer cells by CAFs were predictive of poor response to endocrine treatment. In conclusion, our work reveals that CAFs directly control the luminal breast cancer phenotype by selectively modulating ER-α expression and transcriptional function, and further proposes novel targets to disrupt the crosstalk between CAFs and tumor cells to reinstate |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| treatment response to endocrine therapy in patients. |  |  |\n|  | Oncogene (2024) 43:1113–1126; [https://doi.org/10.1038/s41388-024-02973-x](https://doi.org/10.1038/s41388-024-02973-x) |  |\n|  |  |  |\n\nINTRODUCTION  \nIt is now widely accepted that a tumor is built through paracrine interactions between malignant cells and their microenvironment. Reciprocal signaling involving cancer cells, immune cells, vascular cells, and cancer-associated ﬁbroblasts (CAFs) promote tumor initiation, expansion, and dissemination. In addition, the tumor microenvironment (TME) is instrumental in shaping the response to both conventional and targeted therapies. Speciﬁcally, we and others have previously demonstrated that CAFs dampen the effect of chemotherapy by engineering a high interstitial ﬂuid pressure and a physical collagen barrier that limit the inﬂux of drug from the vasculature to the tumor parenchyma [1–4] . Similarly, CAFs may reduce the efﬁcacy of both external beam radiotherapy and radioimmunotherapy [5, 6] . More recently, CAFs have been described as immunosuppressive, and depletion of CAF subsets expressing ﬁbroblast activation protein (FAP)-α or α-smooth muscle actin (SMA) sensitizes experimental tumors to immune checkpoint blockade with α-CTLA-4 or α-PD-L1 [7, 8] . Taken together, CAFs emerge as important regulators of drug response to mainstay anti-cancer treatment modalities in a range of malignant diseases, and development of strategies to counteract their contribution to therapeutic resistance are warranted to improve treatment beneﬁt.  \nTreatment of breast cancer is dictated by the molecular subtype of the disease. Whereas luminal, hormone receptorexpressing tumors, are effectively managed by endocrine therapies at early stages, and patients with HER2-ampliﬁed tumors beneﬁt from treatment with HER2-targeted therapies, treatment options for triple-negative breast can","cbCaicO2kM5C9iCD","https://ap.wps.com/l/cbCaicO2kM5C9iCD","pdf",5205524,14,"English","# Introduction\n## Tumor microenvironment and CAF-driven therapy resistance\n## Breast cancer subtype dependence on microenvironmental signaling\n## Study approach and mechanistic focus on ER-α signaling","[{\"question\":\"How do cancer-associated fibroblasts influence estrogen receptor (ER)-α in luminal breast cancer?\",\"answer\":\"Spatial CAF infiltration is associated with reduced ER-α expression and activity. CAFs also selectively modulate ER-α signaling to drive estrogen-independent tumor growth.\"},{\"question\":\"Which gene programs are affected by CAF-mediated regulation of ER-α?\",\"answer\":\"Most prototypical estrogen-responsive genes are suppressed. At the same time, CAFs maintain gene expression linked to therapeutic resistance, basal-like differentiation, and invasion.\"},{\"question\":\"What signaling pathways were identified as actionable targets to counter CAF effects on ER-α activity?\",\"answer\":\"A functional drug screen implicated effector pathways. Transforming Growth Factor-β and Janus kinase signaling cascades were validated as actionable targets.\"}]","Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence | PDF",1790020004,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/389530eabf8522ade5263876f05ed2c5.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/040e93bf9c990081c53c6820fed785de.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8312e3143f65151aca6ad53fe5a7de5.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/105175863b1fa8e4184da6a36404cb3a.webp",980,1301]